25 XP   0   0   10

Intech Biopharm Ltd
Buy, Hold or Sell?

Let's analyse Intech Biopharm Ltd together

PenkeI guess you are interested in Intech Biopharm Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Intech Biopharm Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Intech Biopharm Ltd

I send you an email if I find something interesting about Intech Biopharm Ltd.

Quick analysis of Intech Biopharm Ltd (30 sec.)










What can you expect buying and holding a share of Intech Biopharm Ltd? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
NT$8.50
Expected worth in 1 year
NT$9.49
How sure are you?
21.4%

+ What do you gain per year?

Total Gains per Share
NT$0.99
Return On Investment
3.6%

For what price can you sell your share?

Current Price per Share
NT$27.30
Expected price per share
NT$26.50 - NT$27.70
How sure are you?
50%

1. Valuation of Intech Biopharm Ltd (5 min.)




Live pricePrice per Share (EOD)

NT$27.30

Intrinsic Value Per Share

NT$-22.65 - NT$-26.59

Total Value Per Share

NT$-14.15 - NT$-18.09

2. Growth of Intech Biopharm Ltd (5 min.)




Is Intech Biopharm Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$35.8m$35.4m-$6.2m-21.4%

How much money is Intech Biopharm Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$2.5m-$2.5m-$77.5k-3.0%
Net Profit Margin-1,504.2%-1,844.0%--

How much money comes from the company's main activities?

3. Financial Health of Intech Biopharm Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#513 / 1010

Most Revenue
#597 / 1010

Most Profit
#336 / 1010

Most Efficient
#827 / 1010

What can you expect buying and holding a share of Intech Biopharm Ltd? (5 min.)

Welcome investor! Intech Biopharm Ltd's management wants to use your money to grow the business. In return you get a share of Intech Biopharm Ltd.

What can you expect buying and holding a share of Intech Biopharm Ltd?

First you should know what it really means to hold a share of Intech Biopharm Ltd. And how you can make/lose money.

Speculation

The Price per Share of Intech Biopharm Ltd is NT$27.30. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Intech Biopharm Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Intech Biopharm Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$8.50. Based on the TTM, the Book Value Change Per Share is NT$0.25 per quarter. Based on the YOY, the Book Value Change Per Share is NT$-0.56 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Intech Biopharm Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps-0.02-0.1%-0.02-0.1%-0.02-0.1%-0.02-0.1%-0.02-0.1%
Usd Book Value Change Per Share0.080.3%0.010.0%-0.02-0.1%0.020.1%0.020.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.080.3%0.010.0%-0.02-0.1%0.020.1%0.020.1%
Usd Price Per Share0.92-0.93-0.94-0.81-0.81-
Price to Earnings Ratio-10.46--12.58--12.88--11.62--11.62-
Price-to-Total Gains Ratio11.09--38.09--55.80--38.22--38.22-
Price to Book Ratio3.52-4.48-3.72-3.33-3.33-
Price-to-Total Gains Ratio11.09--38.09--55.80--38.22--38.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.83811
Number of shares1193
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.02
Usd Total Gains Per Share0.010.02
Gains per Quarter (1193 shares)9.0722.23
Gains per Year (1193 shares)36.2988.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10362608979
2073620178168
30109980267257
401451340356346
501811700445435
602182060534524
702542420623613
802902780711702
903273140800791
1003633500889880

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.014.00.00.0%0.014.00.00.0%0.014.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%3.011.00.021.4%3.011.00.021.4%3.011.00.021.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.014.00.0%0.00.014.00.0%0.00.014.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%3.011.00.021.4%3.011.00.021.4%3.011.00.021.4%

Fundamentals of Intech Biopharm Ltd

About Intech Biopharm Ltd

Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.

Fundamental data was last updated by Penke on 2024-04-20 16:40:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Intech Biopharm Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Intech Biopharm Ltd earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Intech Biopharm Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -1,804.1% means that NT$-18.04 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Intech Biopharm Ltd:

  • The MRQ is -1,804.1%. The company is making a huge loss. -2
  • The TTM is -1,504.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,804.1%TTM-1,504.2%-299.9%
TTM-1,504.2%YOY-1,844.0%+339.9%
TTM-1,504.2%5Y-1,456.1%-48.1%
5Y-1,456.1%10Y-1,456.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,804.1%-207.2%-1,596.9%
TTM-1,504.2%-218.5%-1,285.7%
YOY-1,844.0%-284.8%-1,559.2%
5Y-1,456.1%-435.1%-1,021.0%
10Y-1,456.1%-589.3%-866.8%
1.1.2. Return on Assets

Shows how efficient Intech Biopharm Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Intech Biopharm Ltd to the Biotechnology industry mean.
  • -3.6% Return on Assets means that Intech Biopharm Ltd generated NT$-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Intech Biopharm Ltd:

  • The MRQ is -3.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.6%TTM-3.3%-0.3%
TTM-3.3%YOY-3.2%-0.1%
TTM-3.3%5Y-3.1%-0.2%
5Y-3.1%10Y-3.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.6%-13.2%+9.6%
TTM-3.3%-12.7%+9.4%
YOY-3.2%-11.5%+8.3%
5Y-3.1%-13.8%+10.7%
10Y-3.1%-15.5%+12.4%
1.1.3. Return on Equity

Shows how efficient Intech Biopharm Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Intech Biopharm Ltd to the Biotechnology industry mean.
  • -8.4% Return on Equity means Intech Biopharm Ltd generated NT$-0.08 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Intech Biopharm Ltd:

  • The MRQ is -8.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.4%TTM-9.0%+0.6%
TTM-9.0%YOY-7.2%-1.8%
TTM-9.0%5Y-7.1%-1.9%
5Y-7.1%10Y-7.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.4%-16.8%+8.4%
TTM-9.0%-16.0%+7.0%
YOY-7.2%-14.8%+7.6%
5Y-7.1%-19.3%+12.2%
10Y-7.1%-20.0%+12.9%

1.2. Operating Efficiency of Intech Biopharm Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Intech Biopharm Ltd is operating .

  • Measures how much profit Intech Biopharm Ltd makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Intech Biopharm Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Intech Biopharm Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-699.4%+699.4%
TTM-699.4%YOY-1,790.5%+1,091.0%
TTM-699.4%5Y-1,194.8%+495.4%
5Y-1,194.8%10Y-1,194.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.8%+299.8%
TTM-699.4%-239.2%-460.2%
YOY-1,790.5%-295.4%-1,495.1%
5Y-1,194.8%-485.9%-708.9%
10Y-1,194.8%-624.6%-570.2%
1.2.2. Operating Ratio

Measures how efficient Intech Biopharm Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 27.26 means that the operating costs are NT$27.26 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of Intech Biopharm Ltd:

  • The MRQ is 27.263. The company is inefficient in keeping operating costs low. -1
  • The TTM is 23.503. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ27.263TTM23.503+3.760
TTM23.503YOY28.471-4.968
TTM23.5035Y22.925+0.578
5Y22.92510Y22.9250.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ27.2633.238+24.025
TTM23.5033.313+20.190
YOY28.4713.838+24.633
5Y22.9255.675+17.250
10Y22.9257.612+15.313

1.3. Liquidity of Intech Biopharm Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Intech Biopharm Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.22 means the company has NT$1.22 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of Intech Biopharm Ltd:

  • The MRQ is 1.222. The company is just able to pay all its short-term debts.
  • The TTM is 0.974. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.222TTM0.974+0.248
TTM0.974YOY3.085-2.111
TTM0.9745Y1.858-0.884
5Y1.85810Y1.8580.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2223.870-2.648
TTM0.9744.173-3.199
YOY3.0855.332-2.247
5Y1.8586.126-4.268
10Y1.8586.448-4.590
1.3.2. Quick Ratio

Measures if Intech Biopharm Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Intech Biopharm Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.92 means the company can pay off NT$0.92 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Intech Biopharm Ltd:

  • The MRQ is 0.920. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.607. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.920TTM0.607+0.314
TTM0.607YOY1.796-1.190
TTM0.6075Y0.896-0.289
5Y0.89610Y0.8960.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9203.510-2.590
TTM0.6073.994-3.387
YOY1.7965.357-3.561
5Y0.8966.105-5.209
10Y0.8966.404-5.508

1.4. Solvency of Intech Biopharm Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Intech Biopharm Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Intech Biopharm Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.57 means that Intech Biopharm Ltd assets are financed with 56.9% credit (debt) and the remaining percentage (100% - 56.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Intech Biopharm Ltd:

  • The MRQ is 0.569. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.627. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.569TTM0.627-0.058
TTM0.627YOY0.544+0.083
TTM0.6275Y0.548+0.079
5Y0.54810Y0.5480.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5690.339+0.230
TTM0.6270.336+0.291
YOY0.5440.271+0.273
5Y0.5480.368+0.180
10Y0.5480.388+0.160
1.4.2. Debt to Equity Ratio

Measures if Intech Biopharm Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Intech Biopharm Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 132.1% means that company has NT$1.32 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Intech Biopharm Ltd:

  • The MRQ is 1.321. The company is able to pay all its debts with equity. +1
  • The TTM is 1.707. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.321TTM1.707-0.385
TTM1.707YOY1.213+0.494
TTM1.7075Y1.265+0.442
5Y1.26510Y1.2650.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3210.390+0.931
TTM1.7070.402+1.305
YOY1.2130.339+0.874
5Y1.2650.428+0.837
10Y1.2650.461+0.804

2. Market Valuation of Intech Biopharm Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Intech Biopharm Ltd generates.

  • Above 15 is considered overpriced but always compare Intech Biopharm Ltd to the Biotechnology industry mean.
  • A PE ratio of -10.46 means the investor is paying NT$-10.46 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Intech Biopharm Ltd:

  • The EOD is -9.551. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.460. Based on the earnings, the company is expensive. -2
  • The TTM is -12.578. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.551MRQ-10.460+0.910
MRQ-10.460TTM-12.578+2.118
TTM-12.578YOY-12.877+0.299
TTM-12.5785Y-11.616-0.962
5Y-11.61610Y-11.6160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.551-2.296-7.255
MRQ-10.460-2.600-7.860
TTM-12.578-2.726-9.852
YOY-12.877-4.145-8.732
5Y-11.616-6.259-5.357
10Y-11.616-6.348-5.268
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Intech Biopharm Ltd:

  • The EOD is -12.362. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -13.539. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -19.041. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.362MRQ-13.539+1.177
MRQ-13.539TTM-19.041+5.502
TTM-19.041YOY-21.538+2.497
TTM-19.0415Y-17.525-1.516
5Y-17.52510Y-17.5250.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.362-2.937-9.425
MRQ-13.539-3.326-10.213
TTM-19.041-3.553-15.488
YOY-21.538-5.605-15.933
5Y-17.525-8.385-9.140
10Y-17.525-8.882-8.643
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Intech Biopharm Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.52 means the investor is paying NT$3.52 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of Intech Biopharm Ltd:

  • The EOD is 3.212. Based on the equity, the company is fair priced.
  • The MRQ is 3.518. Based on the equity, the company is fair priced.
  • The TTM is 4.483. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.212MRQ3.518-0.306
MRQ3.518TTM4.483-0.965
TTM4.483YOY3.717+0.766
TTM4.4835Y3.333+1.149
5Y3.33310Y3.3330.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.2121.909+1.303
MRQ3.5182.114+1.404
TTM4.4832.096+2.387
YOY3.7172.884+0.833
5Y3.3333.554-0.221
10Y3.3333.938-0.605
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Intech Biopharm Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.6950.248+988%-0.557+121%0.607+344%0.607+344%
Book Value Per Share--8.4996.915+23%8.392+1%8.326+2%8.326+2%
Current Ratio--1.2220.974+26%3.085-60%1.858-34%1.858-34%
Debt To Asset Ratio--0.5690.627-9%0.544+5%0.548+4%0.548+4%
Debt To Equity Ratio--1.3211.707-23%1.213+9%1.265+4%1.265+4%
Dividend Per Share----0%-0%-0%-0%
Eps---0.715-0.615-14%-0.597-17%-0.571-20%-0.571-20%
Free Cash Flow Per Share---0.552-0.426-23%-0.366-34%-0.392-29%-0.392-29%
Free Cash Flow To Equity Per Share---0.552-0.312-43%0.068-913%0.037-1575%0.037-1575%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---26.589--------
Intrinsic Value_10Y_min---22.649--------
Intrinsic Value_1Y_max---1.753--------
Intrinsic Value_1Y_min---1.721--------
Intrinsic Value_3Y_max---5.961--------
Intrinsic Value_3Y_min---5.676--------
Intrinsic Value_5Y_max---11.006--------
Intrinsic Value_5Y_min---10.156--------
Market Cap3751238400.000-10%4108514150.0004178924537.500-2%4204684800.000-2%3639350096.429+13%3639350096.429+13%
Net Profit Margin---18.041-15.042-17%-18.440+2%-14.561-19%-14.561-19%
Operating Margin----6.9940%-17.9050%-11.9480%-11.9480%
Operating Ratio--27.26323.503+16%28.471-4%22.925+19%22.925+19%
Pb Ratio3.212-10%3.5184.483-22%3.717-5%3.333+6%3.333+6%
Pe Ratio-9.551+9%-10.460-12.578+20%-12.877+23%-11.616+11%-11.616+11%
Price Per Share27.300-10%29.90030.413-2%30.600-2%26.486+13%26.486+13%
Price To Free Cash Flow Ratio-12.362+9%-13.539-19.041+41%-21.538+59%-17.525+29%-17.525+29%
Price To Total Gains Ratio10.130-10%11.095-38.085+443%-55.798+603%-38.221+444%-38.221+444%
Quick Ratio--0.9200.607+52%1.796-49%0.896+3%0.896+3%
Return On Assets---0.036-0.033-8%-0.032-11%-0.031-14%-0.031-14%
Return On Equity---0.084-0.090+7%-0.072-14%-0.071-16%-0.071-16%
Total Gains Per Share--2.6950.248+988%-0.557+121%0.607+344%0.607+344%
Usd Book Value--35852933.60029170034.800+23%35402771.825+1%35124604.607+2%35124604.607+2%
Usd Book Value Change Per Share--0.0830.008+988%-0.017+121%0.019+344%0.019+344%
Usd Book Value Per Share--0.2610.212+23%0.258+1%0.256+2%0.256+2%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.022-0.019-14%-0.018-17%-0.018-20%-0.018-20%
Usd Free Cash Flow---2329024.800-1798559.500-23%-1545660.575-34%-1651545.971-29%-1651545.971-29%
Usd Free Cash Flow Per Share---0.017-0.013-23%-0.011-34%-0.012-29%-0.012-29%
Usd Free Cash Flow To Equity Per Share---0.017-0.010-43%0.002-913%0.001-1575%0.001-1575%
Usd Market Cap115163018.880-10%126131384.405128292983.301-2%129083823.360-2%111728047.960+13%111728047.960+13%
Usd Price Per Share0.838-10%0.9180.934-2%0.939-2%0.813+13%0.813+13%
Usd Profit---3014586.500-2594050.225-14%-2516455.975-17%-2408623.321-20%-2408623.321-20%
Usd Revenue--167100.100198375.725-16%181490.725-8%214312.314-22%214312.314-22%
Usd Total Gains Per Share--0.0830.008+988%-0.017+121%0.019+344%0.019+344%
 EOD+2 -6MRQTTM+15 -17YOY+12 -205Y+12 -2010Y+12 -20

3.2. Fundamental Score

Let's check the fundamental score of Intech Biopharm Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.551
Price to Book Ratio (EOD)Between0-13.212
Net Profit Margin (MRQ)Greater than0-18.041
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.920
Current Ratio (MRQ)Greater than11.222
Debt to Asset Ratio (MRQ)Less than10.569
Debt to Equity Ratio (MRQ)Less than11.321
Return on Equity (MRQ)Greater than0.15-0.084
Return on Assets (MRQ)Greater than0.05-0.036
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Intech Biopharm Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.960
Ma 20Greater thanMa 5027.715
Ma 50Greater thanMa 10028.469
Ma 100Greater thanMa 20028.563
OpenGreater thanClose27.750
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets2,711,068
Total Liabilities1,543,220
Total Stockholder Equity1,167,848
 As reported
Total Liabilities 1,543,220
Total Stockholder Equity+ 1,167,848
Total Assets = 2,711,068

Assets

Total Assets2,711,068
Total Current Assets695,021
Long-term Assets2,016,047
Total Current Assets
Cash And Cash Equivalents 77,729
Short-term Investments 520,400
Net Receivables 3,047
Inventory 41,525
Other Current Assets 5
Total Current Assets  (as reported)695,021
Total Current Assets  (calculated)642,706
+/- 52,315
Long-term Assets
Property Plant Equipment 1,900,253
Long-term Assets Other 16,740
Long-term Assets  (as reported)2,016,047
Long-term Assets  (calculated)1,916,993
+/- 99,054

Liabilities & Shareholders' Equity

Total Current Liabilities568,726
Long-term Liabilities974,494
Total Stockholder Equity1,167,848
Total Current Liabilities
Short Long Term Debt 464,647
Accounts payable 309
Other Current Liabilities 831
Total Current Liabilities  (as reported)568,726
Total Current Liabilities  (calculated)465,787
+/- 102,939
Long-term Liabilities
Long term Debt 970,407
Long-term Liabilities Other 1,742
Long-term Liabilities  (as reported)974,494
Long-term Liabilities  (calculated)972,149
+/- 2,345
Total Stockholder Equity
Total Stockholder Equity (as reported)1,167,848
Total Stockholder Equity (calculated)0
+/- 1,167,848
Other
Capital Stock1,374,085
Common Stock Shares Outstanding 137,409
Net Debt 1,357,325
Net Invested Capital 2,602,902
Net Working Capital 126,295
Property Plant and Equipment Gross 1,900,253



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
2,426,330
2,621,478
2,586,572
2,506,018
2,434,082
2,601,625
2,513,982
2,439,399
2,634,763
2,550,501
2,536,396
2,475,720
2,422,884
2,711,068
2,711,0682,422,8842,475,7202,536,3962,550,5012,634,7632,439,3992,513,9822,601,6252,434,0822,506,0182,586,5722,621,4782,426,330
   > Total Current Assets 
201,237
409,771
390,673
329,125
272,740
456,326
387,820
330,562
545,021
479,063
477,414
436,316
389,393
695,021
695,021389,393436,316477,414479,063545,021330,562387,820456,326272,740329,125390,673409,771201,237
       Cash And Cash Equivalents 
103,059
204,685
178,873
113,042
58,415
220,481
78,726
54,989
121,287
64,819
124,080
114,524
80,943
77,729
77,72980,943114,524124,08064,819121,28754,98978,726220,48158,415113,042178,873204,685103,059
       Short-term Investments 
0
100,000
100,000
100,000
100,000
115,000
200,000
160,000
310,050
310,125
260,100
220,725
220,450
520,400
520,400220,450220,725260,100310,125310,050160,000200,000115,000100,000100,000100,000100,0000
       Net Receivables 
11,056
37,598
15,495
14,457
12,867
51,886
19,056
20,119
13,760
11,602
14,025
16,859
2,228
3,047
3,0472,22816,85914,02511,60213,76020,11919,05651,88612,86714,45715,49537,59811,056
       Inventory 
57,330
64,470
58,149
61,252
63,252
59,873
56,362
54,128
62,614
51,815
34,370
42,784
34,414
41,525
41,52534,41442,78434,37051,81562,61454,12856,36259,87363,25261,25258,14964,47057,330
       Other Current Assets 
105
0
0
1,011
2,279
4,255
409
22
118
125
574
0
5
5
550574125118224094,2552,2791,01100105
   > Long-term Assets 
2,225,093
2,211,707
2,195,899
2,176,893
2,161,342
2,145,299
2,126,162
2,108,837
2,089,742
2,071,438
2,058,982
2,039,404
2,033,491
2,016,047
2,016,0472,033,4912,039,4042,058,9822,071,4382,089,7422,108,8372,126,1622,145,2992,161,3422,176,8932,195,8992,211,7072,225,093
       Property Plant Equipment 
2,190,155
2,177,877
2,157,120
2,138,487
2,096,433
2,089,655
2,069,778
2,052,647
2,026,879
2,008,704
1,993,367
1,974,662
1,954,672
1,900,253
1,900,2531,954,6721,974,6621,993,3672,008,7042,026,8792,052,6472,069,7782,089,6552,096,4332,138,4872,157,1202,177,8772,190,155
       Other Assets 
30,137
29,078
34,077
33,747
60,271
51,027
51,789
51,616
58,310
57,939
60,841
59,823
0
0
0059,82360,84157,93958,31051,61651,78951,02760,27133,74734,07729,07830,137
> Total Liabilities 
1,040,812
1,292,718
1,324,662
1,325,194
1,324,393
1,263,986
1,243,426
1,251,370
1,512,319
1,518,791
1,583,408
1,593,436
1,625,348
1,543,220
1,543,2201,625,3481,593,4361,583,4081,518,7911,512,3191,251,3701,243,4261,263,9861,324,3931,325,1941,324,6621,292,7181,040,812
   > Total Current Liabilities 
140,393
154,521
191,428
240,674
311,708
323,219
127,745
104,208
112,378
373,822
446,767
479,045
561,606
568,726
568,726561,606479,045446,767373,822112,378104,208127,745323,219311,708240,674191,428154,521140,393
       Short Long Term Debt 
30,000
30,000
64,900
64,900
64,900
211,658
22,297
2,581
10,880
265,255
354,238
375,143
453,447
464,647
464,647453,447375,143354,238265,25510,8802,58122,297211,65864,90064,90064,90030,00030,000
       Accounts payable 
344
1,015
3,352
1,856
3,168
2,402
3,681
1,548
1,736
1,325
20
5,348
5,697
309
3095,6975,348201,3251,7361,5483,6812,4023,1681,8563,3521,015344
       Other Current Liabilities 
86,890
91,062
89,524
87,312
86,680
88,339
85,831
84,133
83,937
107,242
84,188
393,697
749
831
831749393,69784,188107,24283,93784,13385,83188,33986,68087,31289,52491,06286,890
   > Long-term Liabilities 
900,419
1,138,197
1,133,234
1,084,520
1,012,685
940,767
1,115,681
1,147,162
1,399,941
1,144,969
1,136,641
1,114,391
1,063,742
974,494
974,4941,063,7421,114,3911,136,6411,144,9691,399,9411,147,1621,115,681940,7671,012,6851,084,5201,133,2341,138,197900,419
       Long term Debt 
900,419
1,138,197
1,133,234
1,084,520
1,012,685
940,767
1,115,681
1,146,048
1,398,400
1,143,428
1,135,100
1,112,850
1,062,201
970,407
970,4071,062,2011,112,8501,135,1001,143,4281,398,4001,146,0481,115,681940,7671,012,6851,084,5201,133,2341,138,197900,419
       Other Liabilities 
0
0
0
0
0
0
0
1,114
1,541
1,541
1,541
1,541
0
0
001,5411,5411,5411,5411,1140000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
1,114
1,541
1,541
1,541
1,541
1,541
1,742
1,7421,5411,5411,5411,5411,5411,1140000000
> Total Stockholder Equity
1,385,518
1,328,760
1,261,910
1,180,824
1,109,689
1,337,639
1,270,556
1,188,029
1,122,444
1,031,710
952,988
882,284
797,536
1,167,848
1,167,848797,536882,284952,9881,031,7101,122,4441,188,0291,270,5561,337,6391,109,6891,180,8241,261,9101,328,7601,385,518
   Common Stock
1,007,440
1,007,250
1,007,010
1,006,956
1,006,860
1,162,790
1,162,790
1,162,615
1,168,090
1,169,570
1,169,330
1,169,330
0
0
001,169,3301,169,3301,169,5701,168,0901,162,6151,162,7901,162,7901,006,8601,006,9561,007,0101,007,2501,007,440
   Retained Earnings Total Equity00000000000000
   Accumulated Other Comprehensive Income 00000000000000
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 00-145-2,461-5,134-8,2090-2,232-4,7170-661-1,685-2,698-5,004



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue25,847
Cost of Revenue-189,842
Gross Profit-163,995-163,995
 
Operating Income (+$)
Gross Profit-163,995
Operating Expense-346,315
Operating Income-320,468-510,310
 
Operating Expense (+$)
Research Development104,486
Selling General Administrative51,987
Selling And Marketing Expenses0
Operating Expense346,315156,473
 
Net Interest Income (+$)
Interest Income4,422
Interest Expense-33,591
Other Finance Cost-0
Net Interest Income-29,169
 
Pretax Income (+$)
Operating Income-320,468
Net Interest Income-29,169
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-337,987-320,468
EBIT - interestExpense = -33,591
-337,987
-304,396
Interest Expense33,591
Earnings Before Interest and Taxes (EBIT)0-304,396
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-337,987
Tax Provision-0
Net Income From Continuing Ops-337,987-337,987
Net Income-337,987
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net029,169
 

Technical Analysis of Intech Biopharm Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Intech Biopharm Ltd. The general trend of Intech Biopharm Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Intech Biopharm Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Intech Biopharm Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 27.50 < 27.50 < 27.70.

The bearish price targets are: 26.65 > 26.65 > 26.50.

Tweet this
Intech Biopharm Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Intech Biopharm Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Intech Biopharm Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Intech Biopharm Ltd. The current macd is -0.34254707.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Intech Biopharm Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Intech Biopharm Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Intech Biopharm Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Intech Biopharm Ltd Daily Moving Average Convergence/Divergence (MACD) ChartIntech Biopharm Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Intech Biopharm Ltd. The current adx is 18.73.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Intech Biopharm Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Intech Biopharm Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Intech Biopharm Ltd. The current sar is 28.55.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Intech Biopharm Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Intech Biopharm Ltd. The current rsi is 42.96. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Intech Biopharm Ltd Daily Relative Strength Index (RSI) ChartIntech Biopharm Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Intech Biopharm Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Intech Biopharm Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Intech Biopharm Ltd Daily Stochastic Oscillator ChartIntech Biopharm Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Intech Biopharm Ltd. The current cci is -60.70709176.

Intech Biopharm Ltd Daily Commodity Channel Index (CCI) ChartIntech Biopharm Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Intech Biopharm Ltd. The current cmo is -12.45093644.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Intech Biopharm Ltd Daily Chande Momentum Oscillator (CMO) ChartIntech Biopharm Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Intech Biopharm Ltd. The current willr is -55.88235294.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Intech Biopharm Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Intech Biopharm Ltd Daily Williams %R ChartIntech Biopharm Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Intech Biopharm Ltd.

Intech Biopharm Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Intech Biopharm Ltd. The current atr is 0.7106727.

Intech Biopharm Ltd Daily Average True Range (ATR) ChartIntech Biopharm Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Intech Biopharm Ltd. The current obv is 318,023,591.

Intech Biopharm Ltd Daily On-Balance Volume (OBV) ChartIntech Biopharm Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Intech Biopharm Ltd. The current mfi is 44.86.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Intech Biopharm Ltd Daily Money Flow Index (MFI) ChartIntech Biopharm Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Intech Biopharm Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Intech Biopharm Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Intech Biopharm Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.960
Ma 20Greater thanMa 5027.715
Ma 50Greater thanMa 10028.469
Ma 100Greater thanMa 20028.563
OpenGreater thanClose27.750
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Intech Biopharm Ltd with someone you think should read this too:
  • Are you bullish or bearish on Intech Biopharm Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Intech Biopharm Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Intech Biopharm Ltd

I send you an email if I find something interesting about Intech Biopharm Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Intech Biopharm Ltd.

Receive notifications about Intech Biopharm Ltd in your mailbox!